Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 27,354 shares at $32.01 ($876K) on 2023-11-14, disclosed to the SEC on 2023-11-16.
Scheduled sale ($876k) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.01 | 13,677 | $438K | 50.0% |
| 2 | $32.01 | 13,677 | $438K | 50.0% |
| Total | $32.01 avg | 27,354 | $876K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-14 | $240K | — | Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |